Cao AY - Search Results

1

Five common single nucleotide polymorphisms in the PALB2 gene and susceptibility to breast cancer in eastern Chinese population.

Cao AY, Yu KD, Yin WJ, Jin W, Di GH, Shen ZZ, Shao ZM. Cao AY, et al. Breast Cancer Res Treat. 2010 Aug;123(1):133-8. doi: 10.1007/s10549-009-0637-1. Epub 2009 Nov 18. Breast Cancer Res Treat. 2010. PMID: 19921424

2

The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.

Cao AY, Huang J, Hu Z, Li WF, Ma ZL, Tang LL, Zhang B, Su FX, Zhou J, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Yuan WT, Shen ZZ, Huang W, Shao ZM. Cao AY, et al. Breast Cancer Res Treat. 2009 Apr;114(3):457-62. doi: 10.1007/s10549-008-0036-z. Epub 2008 Apr 30. Breast Cancer Res Treat. 2009. PMID: 18446436

3

Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.

Cao AY, Huang J, Hu Z, Li WF, Ma ZL, Tang LL, Zhang B, Su FX, Zhou J, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Yuan WT, Shen ZZ, Huang W, Shao ZM. Cao AY, et al. Breast Cancer Res Treat. 2009 May;115(1):51-5. doi: 10.1007/s10549-008-0052-z. Epub 2008 May 16. Breast Cancer Res Treat. 2009. PMID: 18483852

4

Identification and characterization of two novel germ line p53 mutations in the non-LFS/non-LFL breast cancer families in Chinese population.

Cao AY, Jin W, Shi PC, Di GH, Shen ZZ, Shao ZM. Cao AY, et al. Breast Cancer Res Treat. 2010 Jan;119(2):295-303. doi: 10.1007/s10549-009-0349-6. Epub 2009 Feb 24. Breast Cancer Res Treat. 2010. PMID: 19238535

5

Mutation screening of breast cancer susceptibility genes in Chinese high-risk families: the results will develop the genetic testing strategy in China.

Cao AY, Hu Z, Shao ZM. Cao AY, et al. Breast Cancer Res Treat. 2010 Feb;120(1):271-2. doi: 10.1007/s10549-009-0598-4. Epub 2009 Oct 24. Breast Cancer Res Treat. 2010. PMID: 19856097 No abstract available.

6

Some common mutations of RAD50 and NBS1 in western populations do not contribute significantly to Chinese non-BRCA1/2 hereditary breast cancer.

Cao AY, Hu Z, Yin WJ, Jin W, Shao ZM. Cao AY, et al. Breast Cancer Res Treat. 2010 May;121(1):247-9. doi: 10.1007/s10549-009-0629-1. Epub 2009 Nov 11. Breast Cancer Res Treat. 2010. PMID: 19904603 No abstract available.

7

RAD50 and NBS1 are not likely to be susceptibility genes in Chinese non-BRCA1/2 hereditary breast cancer.

He M, Di GH, Cao AY, Hu Z, Jin W, Shen ZZ, Shao ZM. He M, et al. Among authors: cao ay. Breast Cancer Res Treat. 2012 May;133(1):111-6. doi: 10.1007/s10549-011-1700-2. Epub 2011 Aug 3. Breast Cancer Res Treat. 2012. PMID: 21811815

8

Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China.

Cao AY, He M, Liu ZB, Di GH, Wu J, Lu JS, Liu GY, Shen ZZ, Shao ZM. Cao AY, et al. Ann Surg Oncol. 2012 Sep;19(9):3019-27. doi: 10.1245/s10434-012-2322-6. Epub 2012 Mar 27. Ann Surg Oncol. 2012. PMID: 22451233

9

Tumor characteristics and the clinical outcome of invasive lobular carcinoma compared to infiltrating ductal carcinoma in a Chinese population.

Cao AY, Huang L, Wu J, Lu JS, Liu GY, Shen ZZ, Shao ZM, Di GH. Cao AY, et al. World J Surg Oncol. 2012 Jul 17;10:152. doi: 10.1186/1477-7819-10-152. World J Surg Oncol. 2012. PMID: 22805492 Free PMC article.

10

Influence of a family history of breast and/or ovarian cancer on breast cancer outcomes.

Cao AY, He M, DI GH, Wu J, Lu JS, Liu GY, Shen ZZ, Shao ZM. Cao AY, et al. Exp Ther Med. 2011 Sep;2(5):917-923. doi: 10.3892/etm.2011.275. Epub 2011 May 26. Exp Ther Med. 2011. PMID: 22977598 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters